---
figid: PMC7965852__18_2020_3691_Fig2_HTML
figlink: pmc/articles/PMC7965852/figure/Fig2/
number: F2
caption: Mechanisms of lncRNA-mediated lineage transition. Transcription factors (such
  as SOX family), histone-modifying enzymes (such as enhancer of zeste homologue 2
  (EZH2) and RE1-slienicng transcription factor (REST)) regulate the reprogramming
  tumor cells into slow-cycling, drug-tolerant states. LncRNAs such as lincRNA-p21,
  TUG1, linc-PINT, HOXA11-AS, SOX2-OT, FBXL19-AS1, LINC00514, FENDRR are implicated
  in the reprogramming process. Alterations in several key signaling pathways such
  as WNT-β-catenin pathway, IL-6/STAT3 pathway, NF-κB pathway and YAP pathway promote
  phenotypic switching upon TKI treatment. lncRNAs such as MALAT1, GHET1, SNHG1, NEAT1,
  H19 TNK2-AS1 are involved in these key signaling pathways. Crosstalk with the tumor
  microenvironment, through secretion of various cytokines from cancer-associated
  fibroblasts such as hepatocyte growth factor(HGF), growth arrest-specific protein
  6 (GAS6), CXC-chemokine ligand 12 (CXCL12), interleukin-6 (IL-6) and transforming
  growth factorβ (TGFβ); cytokines from endothelial cells such as epidermal growth
  factor (EGF), transforming growth factor-α (TGFα), vascular endothelial growth factor
  (VEGF) and heparin-binding EGF-like growth factor (HB-EGF); Interluekin-6 (IL-6),
  VEGF from tumor-associated macrophage (TAM) controls tumor plasticity. The enhanced
  cell–cell adhesion via increased expression of integrin β1 and N-cadherin in tumor
  cells and increased extracellular matrix (ECM) stiffness via Serpin B2 can also
  promote tyrosine kinase inhibitors (TKI) resistance. LncRNAs involved in the M2
  polarization of macrophage such as XIST and GNAS-AS1 played a part in TKI resistance.
  Lastly, low level of oxygen can active hypoxia-inducible factor 1α (HIF1α) in tumor
  cells, causing autocrine signaling by secretion of TGFα, VEGF and insulin-like growth
  factor (IGF-1), which promotes resistance to TKI therapy. TFs transcription factors,
  CAF cancer-associated fibroblasts
pmcid: PMC7965852
papertitle: 'Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated
  TKI resistance.'
reftext: Tongyan Liu, et al. Cell Mol Life Sci. 2021;78(5):1983-2000.
pmc_ranked_result_index: '41364'
pathway_score: 0.5334126
filename: 18_2020_3691_Fig2_HTML.jpg
figtitle: LncRNA-mediated lineage transition
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7965852__18_2020_3691_Fig2_HTML.html
  '@type': Dataset
  description: Mechanisms of lncRNA-mediated lineage transition. Transcription factors
    (such as SOX family), histone-modifying enzymes (such as enhancer of zeste homologue
    2 (EZH2) and RE1-slienicng transcription factor (REST)) regulate the reprogramming
    tumor cells into slow-cycling, drug-tolerant states. LncRNAs such as lincRNA-p21,
    TUG1, linc-PINT, HOXA11-AS, SOX2-OT, FBXL19-AS1, LINC00514, FENDRR are implicated
    in the reprogramming process. Alterations in several key signaling pathways such
    as WNT-β-catenin pathway, IL-6/STAT3 pathway, NF-κB pathway and YAP pathway promote
    phenotypic switching upon TKI treatment. lncRNAs such as MALAT1, GHET1, SNHG1,
    NEAT1, H19 TNK2-AS1 are involved in these key signaling pathways. Crosstalk with
    the tumor microenvironment, through secretion of various cytokines from cancer-associated
    fibroblasts such as hepatocyte growth factor(HGF), growth arrest-specific protein
    6 (GAS6), CXC-chemokine ligand 12 (CXCL12), interleukin-6 (IL-6) and transforming
    growth factorβ (TGFβ); cytokines from endothelial cells such as epidermal growth
    factor (EGF), transforming growth factor-α (TGFα), vascular endothelial growth
    factor (VEGF) and heparin-binding EGF-like growth factor (HB-EGF); Interluekin-6
    (IL-6), VEGF from tumor-associated macrophage (TAM) controls tumor plasticity.
    The enhanced cell–cell adhesion via increased expression of integrin β1 and N-cadherin
    in tumor cells and increased extracellular matrix (ECM) stiffness via Serpin B2
    can also promote tyrosine kinase inhibitors (TKI) resistance. LncRNAs involved
    in the M2 polarization of macrophage such as XIST and GNAS-AS1 played a part in
    TKI resistance. Lastly, low level of oxygen can active hypoxia-inducible factor
    1α (HIF1α) in tumor cells, causing autocrine signaling by secretion of TGFα, VEGF
    and insulin-like growth factor (IGF-1), which promotes resistance to TKI therapy.
    TFs transcription factors, CAF cancer-associated fibroblasts
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - HGF
  - IL6
  - TGFA
  - GAS6
  - TGFB1
  - TGFB2
  - TGFB3
  - BCL2
  - CXCL12
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - EGF
  - HBEGF
  - IGF1R
  - EZH2
  - REST
  - SERPINB2
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - YY1AP1
  - HRAS
  - KRAS
  - NRAS
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - WNT1
  - WNT5A
  - WNT6
  - WNT7A
  - WNT8A
  - WNT8B
  - WNT10B
  - WNT2B
  - WNT16
  - WNT2
  - WNT3
  - WNT7B
  - WNT11
  - WNT9A
  - WNT9B
  - WNT4
  - WNT10A
  - WNT5B
  - WNT3A
  - CDH2
  - MMRN1
genes:
- word: •IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: •HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: •IL-6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: •TGFA
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: •GAS6
  symbol: GAS6
  source: hgnc_symbol
  hgnc_symbol: GAS6
  entrez: '2621'
- word: •TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: •TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: •TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: •BCL2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: •CXCL12
  symbol: CXCL12
  source: hgnc_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: •EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: •TGFA
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: •HB-EGF
  symbol: HBEGF
  source: hgnc_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: EZH2
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: REST
  symbol: REST
  source: hgnc_symbol
  hgnc_symbol: REST
  entrez: '5978'
- word: SerpinB2
  symbol: SERPINB2
  source: hgnc_symbol
  hgnc_symbol: SERPINB2
  entrez: '5055'
- word: •MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: •MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: •MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: •MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: •MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: •MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: •MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: •MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: •MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: •YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: •RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: •RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: •RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: •NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: •NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: •NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: •NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: •NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: •WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: •IL-6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: N-cadherin
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: •VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: ЕСМ
  symbol: ECM
  source: hgnc_alias_symbol
  hgnc_symbol: MMRN1
  entrez: '22915'
chemicals: []
diseases: []
figid_alias: PMC7965852__F2
redirect_from: /figures/PMC7965852__F2
figtype: Figure
---
